Protective action of calcium channel antagonist agents against ventricular fibrillation in the isolated perfused rat heart.
D000227:Adenine Nucleotides / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D003326:Coronary Circulation; D003327:Coronary Disease / Q000150:complications; D000242:Cyclic AMP / Q000378:metabolism; D004110:Diltiazem / Q000494:pharmacology; D007473:Ion Channels / Q000378:metabolism*; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009543:Nifedipine / Q000494:pharmacology; D051381:Rats; D014693:Ventricular Fibrillation / Q000209:etiology / Q000517:prevention & control*; D014700:Verapamil / Q000494:pharmacology
D000227:Adenine Nucleotides; D007473:Ion Channels; D014700:Verapamil; D000242:Cyclic AMP; D004110:Diltiazem; D009543:Nifedipine; D002118:Calcium